You are here

Mark Brager
January 10, 2014

AdvaMed Applauds Introduction of the Congressional Trade Priorities Act

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) released the following statement by Ralph Ives, Executive Vice President for Global Strategy and Analysis, upon the introduction of the Congressional Trade Priorities Act (TPA) of 2014 by the U.S. Senate Finance Committee and the U.S. House of Representatives Ways and Means Committee:

“AdvaMed applauds the leadership of Finance Committee Chairman Sen. Max Baucus (D-MT), Ways and Means Chairman Rep. Dave Camp (R-MI) and U.S. Sen. Orrin Hatch (R-UT) for introducing TPA. We are pleased that TPA includes a list of key negotiating objectives for U.S. free trade agreements and procedures for Congress to consider as they address trade legislation. The TPA will help ensure trade agreements are implemented in a fixed time period and without amendments. 

“Our members support free trade and believe TPA is necessary to guide and strengthen USTR’s negotiating objectives in trade negotiations. We also appreciate that this TPA enhances previous versions by adding new negotiating objectives on transparency and procedural fairness in reimbursement decisions, price controls, trade secrets and localization – all issues our members face in a growing list of countries.”

# # #

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies.